Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 19, 2023 - Issue 8: Chronic rhinosinusitis
Submit an article Journal homepage
2,233
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making

Josje Ottena Department of Otorhinolaryngology & Head and Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsCorrespondence[email protected]
View further author information
,
Rik van der Lansa Department of Otorhinolaryngology & Head and Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-5361-6752View further author information
ORCID Icon,
Eugenio de Corsob Unit of Otorhinolaryngology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, ItalyView further author information
,
kanstantsin Dziadziuliac Center for Rhinology and Allergology, Wiesbaden, GermanyView further author information
,
Bart Hilveringd Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The NetherlandsView further author information
,
Els Weersinkd Department of Pulmonary Medicine, Amsterdam UMC, Amsterdam, The NetherlandsView further author information
,
Matteo Boninie Department of Internal Medicine and Geriatrics, Catholic University of the Sacred Hearth, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-9326-1370View further author information
ORCID Icon,
Jan Hagemannf Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, GermanyView further author information
,
Wanrawee Thaitrakoola Department of Otorhinolaryngology & Head and Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands;g Department of Otolaryngology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandView further author information
,
Claudio Montuorih Head and Neck and Sensory Organs Department, Università Cattolica Del Sacro Cuore, Rome, ItalyView further author information
,
Ludger Klimekc Center for Rhinology and Allergology, Wiesbaden, GermanyORCID Iconhttps://orcid.org/0000-0002-2455-0192View further author information
ORCID Icon,
Sietze Reitsmaa Department of Otorhinolaryngology & Head and Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsView further author information
&
Wytske Fokkensa Department of Otorhinolaryngology & Head and Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsView further author information
 show all
Pages 1041-1049 | Received 21 Feb 2023, Accepted 23 May 2023, Published online: 29 May 2023

References

  • Hopkins C, Surda P, Walker A, et al. EPOS 4 Patients. Rhinology. 2021;0(0):1–57. DOI:10.4193/Rhin20.950
  • Hellings PW, Fokkens WJ, Orlandi R, et al. The EUFOREA pocket guide for chronic rhinosinusitis. Rhinology. 2022;0(0):0–0. DOI:10.4193/Rhin22.344
  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. DOI:10.4193/Rhin20.401
  • Porsbjerg CM, Menzies-Gow AN, Tran TN, et al. Global variability in administrative approval prescription criteria for biologic therapy in severe asthma. J Allergy Clin Immunol Pract. 2022;10(5):1202–16.e23. DOI:10.1016/j.jaip.2021.12.027
  • Agache I, Song Y, Alonso-Coello P, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337–2353. DOI:10.1111/all.14809
  • Agache I, Beltran J, Akdis C, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020;75(5):1023–1042. DOI:10.1111/all.14221
  • van der Lans RJL, Fokkens WJ, Adriaensen G, et al. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps. Allergy. 2022;77(2):670–674. DOI:10.1111/all.15134
  • De Corso E, Settimi S, Montuori C, et al. Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a “Real-life” observational study in the first year of treatment. J Clin Med. 2022;11(10):2684. DOI:10.3390/jcm11102684
  • Menzies-Gow AN, McBrien C, Unni B, et al. Real world biologic use and switch patterns in severe asthma: data from the international severe asthma registry and the US CHRONICLE study. J Asthma Allergy. 2022;15:63–78.
  • Kallieri M, Zervas E, Fouka E, et al. Relight: a two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asThma in Greece: evaluating the multiple components of response. European Respiratory Journal. 2022;60:468. DOI:10.1183/13993003.congress-2022.468
  • Campo P, Soto Campos G, Moreira A, et al. Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment. Allergy. 2021;76(6):1868–1872. DOI:10.1111/all.14668
  • Renner A, Marth K, Patocka K, et al. Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics. Allergy. 2020;75(12):3272–3275.
  • Pavord ID, Hanania NA, Corren J. Controversies in allergy: choosing a biologic for patients with severe asthma. J Allergy Clin Immunol Pract. 2022;10(2):410–419. DOI:10.1016/j.jaip.2021.12.014
  • Peters AT, Han JK, Hellings P, et al. Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2021;9(6):2461–71 e5. DOI:10.1016/j.jaip.2021.01.031
  • Bavaro N, Gakpo D, Mittal A, et al. Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Ralpha in a real-world setting. J Allergy Clin Immunol Pract. 2021;9(7):2910–2 e1. DOI:10.1016/j.jaip.2021.02.020
  • Oykhman P, Paramo FA, Bousquet J, et al. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. J Allergy Clin Immunol. 2022;149(4):1286–1295. DOI:10.1016/j.jaci.2021.09.009
  • Akenroye A, Lassiter G, Jackson JW, et al. Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: a Bayesian network meta-analysis. J Allergy Clin Immunol. 2022;150(5):1097–105.e12. DOI:10.1016/j.jaci.2022.05.024
  • Lommatzsch M, Suhling H, Korn S, et al. Safety of combining biologics in severe asthma: asthma-related and unrelated combinations. Allergy. 2022;77(9):2839–2843. DOI:10.1111/all.15379

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.